Long-Term Effects of High-Dose Tolvaptan for Autosomal Dominant Polycystic Kidney Disease Patients. - Nakatani S; Ishimura E; Machiba Y; Fujimoto K; Uedono H; Tsuda A; Mori K; Emoto M; Inaba M (Case reports in nephrology and dialysis, 2020)